Advertisement
TFAS is a novel spinal implant designed to treat spinal stenosis, acondition in which degenerative changes in the facet joints result incompression of spinal nerves producing neurological symptoms in the legs.Traditionally, patients with moderate to severe spinal stenosis undergodecompressive laminectomy surgery, which is often accompanied by spinalfusion. The TFAS replaces the degenerative facet joints with a prostheticjoint implant intended to restore stability and normal motion to the spine,eliminating the need for fusion.
Advertisement
"This is an important milestone for facet arthroplasty and for ArchusOrthopedics," said Jim Fitzsimmons, chairman and chief executive officer."Our study results to date are demonstrating clinically significantimprovement in patient symptoms and function. With longest patient follow-upnow well over two years, we are confident that this is a durable implant andprocedure," he added.
In addition to TFAS, Archus is developing a suite of products to addressother important clinical applications for facet joint replacement. "We expectto report first human implants of these devices this year," said Fitzsimmons.
About Archus Orthopedics
Founded in July 2001, Archus Orthopedics is a privately held companydeveloping a family of reconstructive implants to treat a variety of spinedisorders resulting from degenerative changes in the facet joints. Archus hasreceived venture capital funding from MPM Capital, InterWest Partners, PolarisVenture Partners and Johnson & Johnson Development Corporation, in cooperationwith DePuy Spine.
SOURCE Archus Orthopedics, Inc.
